MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 8, 2004; DOI: 10.1124/mol.104.006072


0026-895X/05/6701-78-87$20.00
Mol Pharmacol 67:78-87, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.006072v1
67/1/78    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stalheim, L.
Right arrow Articles by Trejo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stalheim, L.
Right arrow Articles by Trejo, J.

Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking

Lisa Stalheim, Yu Ding, Anuradha Gullapalli, May M. Paing, Breann L. Wolfe, Dionne R. Morris, and JoAnn Trejo

Departments of Pharmacology and Cell and Developmental Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

The irreversible proteolytic nature of protease-activated receptor-2 (PAR2) activation suggests that mechanism(s) responsible for termination of receptor signaling are critical determinants of the magnitude and duration of PAR2-elicited cellular responses. Rapid desensitization of activated G-protein-coupled receptors (GPCRs) involves both phosphorylation and binding of arrestins. Arrestins also function as scaffolds and transducers of mitogen-activated protein (MAP) kinase signaling cascades. The PAR2 cytoplasmic tail (C-tail) contains multiple sites of phosphorylation and may be an important determinant for arrestin interaction. Desensitization and internalization of activated PAR2 were markedly impaired in arrestin-deficient cells compared with wild-type control cells. PAR2 C-tail truncation mutants displayed normal agonist-induced internalization, caused rapid distribution of {beta}arr2-GFP to the plasma membrane, and desensitized in an arrestin-dependent manner similar to that of wild-type PAR2. It is interesting that PAR2 C-tail mutants lost the capacity to stably associate with arrestins and consequently, redistributed to endocytic vesicles without {beta}arr2-GFP, whereas internalized wild-type PAR2 remained stably associated with {beta}arr2-GFP in endosomes. Moreover, activated PAR2 caused rapid and prolonged activation of endogenous extracellular signal-regulated kinase (ERK1/2). It was striking that in arrestin-deficient cells, activated PAR2 induced an initial peak in ERK1/2 activity that rapidly declined. The inability of internalized PAR2 C-tail mutants to stably associate with arrestins also resulted in loss of prolonged ERK2 activation. Thus, the PAR2 C-tail regulates the stability of arrestin interaction and kinetics of ERK1/2 activation but is not essential for desensitization or internalization. These findings further suggest that the diverse functions of arrestins in regulating PAR2 signaling and trafficking are controlled by multiple independent interactions involving both the intracellular loops and the C-tail.


Received August 11, 2004; accepted October 7, 2004

Address correspondence to: Dr. JoAnn Trejo, Department of Pharmacology, University of North Carolina at Chapel Hill, 1106 Mary Ellen Jones Bldg., Chapel Hill, NC 27599-7365. E-mail: joann_trejo{at}med.unc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Namkung, J. S. Yoon, K. H. Kim, and M. G. Lee
PAR2 exerts local protection against acute pancreatitis via modulation of MAP kinase and MAP kinase phosphatase signaling
Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G886 - G894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qiu, H. H. Loh, and P.-Y. Law
Phosphorylation of the {delta}-Opioid Receptor Regulates Its beta-Arrestins Selectivity and Subsequent Receptor Internalization and Adenylyl Cyclase Desensitization
J. Biol. Chem., August 3, 2007; 282(31): 22315 - 22323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zoudilova, P. Kumar, L. Ge, P. Wang, G. M. Bokoch, and K. A. DeFea
beta-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2
J. Biol. Chem., July 13, 2007; 282(28): 20634 - 20646.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Kumar, C. S. Lau, M. Mathur, P. Wang, and K. A. DeFea
Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C346 - C357.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling
Blood, July 1, 2007; 110(1): 161 - 170.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. L. Wolfe, A. Marchese, and J. Trejo
Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1
J. Cell Biol., June 21, 2007; 177(5): 905 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Bushell
The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders
J. Physiol., May 15, 2007; 581(1): 7 - 16.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Gesty-Palmer, M. Chen, E. Reiter, S. Ahn, C. D. Nelson, S. Wang, A. E. Eckhardt, C. L. Cowan, R. F. Spurney, L. M. Luttrell, et al.
Distinct beta-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
J. Biol. Chem., April 21, 2006; 281(16): 10856 - 10864.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
S. K. Shenoy and R. J. Lefkowitz
Seven-Transmembrane Receptor Signaling Through {beta}-Arrestin
Sci. Signal., November 1, 2005; 2005(308): cm10 - cm10.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Lagane, S. Ballet, T. Planchenault, K. Balabanian, E. Le Poul, C. Blanpain, Y. Percherancier, I. Staropoli, G. Vassart, M. Oppermann, et al.
Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis
Mol. Pharmacol., June 1, 2005; 67(6): 1966 - 1976.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics